Indication

QTL7

1 clinical trial

1 drug

Clinical trial

Effect of Allopurinol on Markers of Mineral and Bone Metabolism in Patients in With Chronic Kidney Disease: a Randomized Double-blind Study

Status: Active (not recruiting), Estimated PCD: 2023-12-30

Drug